We are live on ! Find out more
EXPO icon

Exponent

354 hedge funds and large institutions have $4.17B invested in Exponent in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 117 increasing their positions, 152 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more call options, than puts

Call options by funds: $2.57M | Put options by funds: $1.8M

13% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 38

5% more capital invested

Capital invested by funds: $3.96B → $4.17B (+$212M)

2.7% more ownership

Funds ownership: 90.94%93.64% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less funds holding

Funds holding: 356354 (-2)

23% less repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 152

Holders
354
Holders Change
-2
Holders Change %
-0.56%
% of All Funds
5.16%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
43
Increased
117
Reduced
152
Closed
38
Calls
$2.57M
Puts
$1.8M
Net Calls
+$775K
Net Calls Change
-$56K

EXPO Hedge Fund Activity: Q4 2023 in Review

354 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Exponent (EXPO) for Q4 2023, worth a combined $4.17B — up 5.3% from $3.96B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new EXPO positions and 38 closed out — a net gain of 5 holders — while 117 added to existing stakes and 152 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $75.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $13.6M.

  • 354 institutional investors held Exponent (EXPO) as of Q4 2023, down from 356 in Q3 2023.
  • Funds reported $4.17B of Exponent stock for Q4 2023, up 5.3% quarter-over-quarter.
  • 43 funds opened new Exponent positions in Q4 2023 and 38 closed out, a net change of +5 holders.
  • The largest Exponent buyer in Q4 2023 was Morgan Stanley, an estimated $75.9M added.
  • The largest Exponent seller in Q4 2023 was T. Rowe Price Associates, an estimated $13.6M sold.

Based on aggregated 13F filings for Q4 2023.